Amarantus Bioscience Holdings Inc (AMBS)

[Riskreturn168]

Alapis: Did you really expect Gerald to give a detailed prediction of how much LymPro revenue will be produced in each quarter of next year? They won't even begin commercializing for another 4 months. The best Gerald can do is give us some indication what sources our revenue will be coming from and approximate ranges of revenue in the first half of 2015, second half of 2015, and maybe for 2016 as well.

Ball park ranges of revenue is what I'm expecting, not specific predictions. For example, he might say our first half revenue might be in the 3 to 8 million revenue range. The second half might be in the 15 to 50 million range, and our 2016 in the 150 to 250 million range.

He might not even be able to give as much as I have above. But at least he will be talking about where the revenue will come from and an inkling of what ranges to expect.